Industry Data Insights provides industry-focused research and analytical intelligence for organizations seeking a clearer view of market performance, competitive conditions, and long-term business opportunities. Through syndicated reports, customized studies, and strategic research support, Industry Data Insights helps businesses access the information needed to evaluate markets and plan for sustainable growth. Our research covers the full market landscape, including industry structure, historical performance, current demand, value-chain developments, regional trends, customer requirements, technological change, and future growth potential. We examine the factors that influence market outcomes, including economic conditions, supply-chain dynamics, policy and regulatory developments, innovation, investment activity, and changing end-user preferences.
At Industry Data Insights, we use a research framework that brings together credible secondary sources, public and company-level information, industry publications, trade statistics, expert perspectives, and data-led market modeling. Our analysts validate key assumptions and assess multiple market variables to develop balanced, actionable conclusions for business leaders, investors, consultants, and product teams. Industry Data Insights supports a broad range of verticals, including industrial manufacturing, engineering, construction, chemicals, energy and power, healthcare, information technology, telecom, automotive, packaging, agriculture, consumer products, retail, and transportation. Each study is structured to help users understand both the immediate market environment and the longer-term forces that may influence demand and competition. From identifying high-potential segments to assessing a competitor’s position or evaluating a new geography, Industry Data Insights delivers research that is designed to be useful, relevant, and aligned with real business questions. Our goal is to turn industry data into strategic direction.
Oct 9 2026
274
.jpg){kind=small}
Senior Research Analyst
Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.
See the similar reports
| Market at a Glance | Value |
|---|---|
| Base Year Valuation (2025) | $692.26 million |
| Forecast Valuation (2033) | $979 million |
| CAGR (2025-2033) | 4.43% |
| Forecast Period | 2025-2033 |
| Largest Regional Market | North America (34% share) |
| Dominant Segment | Liquid Bore Connectors (58% revenue) |
The global market for small bore connectors reached $692.26 million in 2025, with a 4.43% CAGR projecting $979 million by 2033. Growth is tied to mandatory ISO 80369 adoption, rising IV therapy volumes, and the shift of infusion care to home settings. The Liquid Bore Connectors Market generates the largest revenue pool, while the Gas Bore Connectors Market serves respiratory and oxygen delivery. North America contributes 34% of global value, but Asia-Pacific is growing at 5.2%.
The IV Therapy Connectors Market is the largest application, accounting for 46% of connector demand. Enteral Feeding Connectors Market growth is supported by ENFit standardization, with compliance nearing 90% in U.S. hospitals. Medical Device Connectors Market expansion is directly linked to infusion pump and catheter innovations. Hospital Consumables Market purchasing cycles and Healthcare Equipment Market capital budgets influence replacement timing. Medical Grade Plastics Market and Thermoplastic Elastomers Market supply critical resins for connector bodies and seals. Overall, the market is a replacement-driven, regulation-paced segment with steady rather than explosive growth.
| Segment Analysis Matrix | CAGR (%) | Market Share (%) | Key Demand Driver |
|---|---|---|---|
| Liquid Bore Connectors | 4.8% | 58% | IV therapy safety mandates (ISO 80369-7) |
| Gas Bore Connectors | 3.5% | 27% | Respiratory care and oxygen delivery |
| Others (Enteral, etc.) | 5.1% | 15% | ENFit enteral feeding transition |
The Liquid Bore Connectors Market holds 58% of global revenue. Liquid bore connectors are used in IV lines, catheters, and infusion sets. The segment benefits from high replacement frequency and strict misconnection prevention rules. Hospitals are the largest buyers, representing 72% of liquid bore connector demand.
The Gas Bore Connectors Market grows at 3.5% CAGR. Demand comes from oxygen therapy, anesthesia, and ventilator circuits. Growth is slower due to longer replacement cycles and reusable metal connectors in some regions. However, home respiratory care adds a 4.1% volume uptick in North America and Europe.
Overall, liquid bore connectors deliver scale; gas bore connectors deliver stable cash flow; enteral connectors deliver the highest growth rate.
| Market Dynamics Impact Analysis | Description | Impact Level | Timeline |
|---|---|---|---|
| Driver | Rising IV therapy procedures (over 1.5 billion annually) | High | Short term |
| Driver | ISO 80369 standards reducing misconnections | High | Long term |
| Driver | Shift to home-care infusion | Medium | Long term |
| Restraint | Raw material price volatility in Medical Grade Plastics Market | Medium | Short term |
| Restraint | Stringent FDA 510(k) and EU MDR costs | High | Long term |
| Restraint | Low replacement cycle in emerging markets | Medium | Short term |
Driver analysis: IV therapy volume is the strongest catalyst. More than 1.5 billion IV procedures occur globally each year, and each procedure uses multiple connectors. ISO 80369-7 compliance mandates replacement of non-compliant luer connectors, creating a $120 million retrofit opportunity. The Medical Device Connectors Market also gains from smart infusion pumps that require validated connector interfaces.
Restraint analysis: Medical Grade Plastics Market volatility affects polycarbonate and polypropylene pricing. In 2022, resin prices rose 18%, compressing OEM margins. Thermoplastic Elastomers Market supply tightened in 2021-2022 due to silicone shortages. Regulatory costs are high: a single FDA 510(k) for a new connector can exceed $250,000 and 12 months. EU MDR adds $80,000 to $150,000 per product for clinical evaluation.
Net impact: drivers outweigh restraints through 2027. The 4.43% CAGR assumes steady replacement demand and no major reimbursement shocks. Hospital Consumables Market consolidation and Healthcare Equipment Market budgeting cycles create quarterly volatility but not structural decline.
| Vendor Benchmarking Matrix | Core Strength | Target Audience | Market Position |
|---|---|---|---|
| Baxter International Inc. | Broad IV therapy and infusion systems | Hospitals, clinics | Leader |
| B. Braun | Infusion pumps and connector integration | Hospitals, home-care | Leader |
| BD | Needle-free connectors and vascular access | Hospitals, ASCs | Leader |
| Smiths Medical - Smiths Group Company | Respiratory and infusion devices | Hospitals, home-care | Challenger |
| ICU Medical Inc | Infusion systems and critical care | Hospitals | Leader |
| Merit Medical Systems, Inc. | Vascular access and custom kits | Hospitals, clinics | Challenger |
| Elcam Medical | OEM connector manufacturing | OEMs, device makers | Niche |
| Nordson Corporation | Precision medical components | OEMs | Challenger |
| CPC (Colder Products Company) | Quick-disconnect connectors | OEMs, medical devices | Niche |
| Latest Strategic Moves | Company | Event Type | Impact |
|---|---|---|---|
| Jan 2022 | ICU Medical Inc | M&A | Acquired Smiths Medical for $2.35B, consolidating infusion and connector portfolios |
| 2023 | BD | Launch | Launched ISO 80369-7 compliant needle-free connector line |
| 2024 | Baxter International | Partnership | Collaborated on ENFit enteral connector education and transition |
| 2023 | Nordson Corporation | Launch | Introduced high-flow liquid bore connector for IV sets |
| 2025 | Elcam Medical | Expansion | Increased OEM capacity for gas bore connectors by 20% |
| Regional Growth Comparison | Projected CAGR (%) | Base Year Valuation | Primary Catalyst | Regulatory Stringency |
|---|---|---|---|---|
| North America | 4.1% | $235.4M | IV therapy safety mandates and hospital consolidation | High (FDA, ISO) |
| Europe | 4.3% | $180.0M | EU MDR compliance and aging population | High (EU MDR, ISO) |
| Asia-Pacific | 5.2% | $193.8M | Expanding hospital infrastructure and medical tourism | Medium (NMPA, PMDA) |
| LAMEA | 3.8% | $83.1M | Rising home-care and infection control | Low to Medium |
Regional winners: APAC offers volume growth; North America offers margin. Europe is a regulatory-driven replacement market. LAMEA is an emerging opportunity for low-cost gas bore connectors.
Upstream dependencies include polycarbonate, polypropylene, thermoplastic elastomers, silicone, and medical-grade adhesives. The Medical Grade Plastics Market supplies connector bodies and luers. The Thermoplastic Elastomers Market provides seals and gaskets. Key resin suppliers include Covestro, SABIC, Dow, and Eastman. Pricing trends: polycarbonate rose 18% in 2022, fell 6% in 2023, and stabilized in 2024. Polypropylene followed a similar pattern with 12% peak-to-trough volatility.
OEMs are dual-sourcing resins and adding regional molding capacity near hospital hubs. This reduces freight risk and lead times but raises unit costs by 4-7%.
Major frameworks include ISO 80369 series, FDA 510(k) premarket notification, EU MDR 2017/745, and REACH. ISO 80369-7 governs intravascular connectors; ISO 80369-3 covers enteral connectors; ISO 80369-6 addresses neural connectors. FDA CDRH enforces 510(k) for new connectors and tracks misconnection reports. EU MDR requires clinical evaluation and post-market surveillance, adding $80,000-$150,000 per product.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 4.43% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Director of Medical Device Procurement | 30% |
| Infection Prevention Manager | 20% |
| Regulatory Affairs Specialist | 20% |
| R&D Engineer for Vascular Access | 15% |
| Chief Nursing Officer | 15% |
| Company Type | Representation (%) |
|---|---|
| Liquid Bore Connector OEMs | 30% |
| Gas Bore Connector OEMs | 20% |
| Medical Device OEMs integrating connectors | 25% |
| Medical Grade Polymer Suppliers | 15% |
| Hospital Group Purchasing Organizations | 10% |
ICU Medical completed the $2.35 billion acquisition of Smiths Medical in January 2022, consolidating infusion and connector portfolios. BD launched an ISO 80369-7 compliant needle-free connector line in 2023. Elcam Medical expanded OEM capacity for gas bore connectors by 20% in 2025.
ISO 80369 certification and FDA 510(k) clearance require 12-18 months and over $250,000 per product. Incumbent OEMs hold proprietary molds and hospital GPO contracts, creating high switching costs. BD and ICU Medical control over 40% of U.S. hospital IV connector share.
North America holds 34% of global revenue, driven by FDA enforcement of ISO 80369-7 and high IV therapy volumes. The U.S. alone accounts for 80% of regional value, supported by hospital consolidation and stringent misconnection reporting. Europe follows at 26% due to EU MDR compliance.
Venture funding is moderate because the market is replacement-driven and dominated by large medtech firms. Strategic M&A exceeds $3 billion since 2020, led by ICU Medical's $2.35 billion Smiths Medical deal. Private equity interest focuses on OEM connector makers with ISO 13485 certification.
Post-pandemic demand rebounded strongly in 2022-2023 as elective IV procedures resumed, with 2024 revenue growing 4.1% year-over-year. Structural shifts include permanent expansion of home-care infusion, which now represents 18% of connector demand. Supply chain dual-sourcing added 4-7% to unit costs but reduced lead times.
Hospitals consume 72% of liquid bore connectors, while ambulatory surgical centers and clinics account for 18%. Home-care is the fastest-growing end use at 5.6% CAGR, driven by infusion therapy and respiratory care. Enteral feeding connectors in long-term care add steady replacement demand.
